Rasagiline monotherapy improves swallowing in patients with Parkinson's disease

被引：2
|
作者：
Hirano, Makito [1 ]
Isono, Chiharu [2 ]
Samukawa, Makoto [1 ]
Fukuda, Kanji [2 ]
Kusunoki, Susumu [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Neurol, Higashiosaka, Osaka, Japan
[2] Kindai Univ, Fac Med, Dept Rehabil Med, Higashiosaka, Osaka, Japan
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 78卷
关键词：
Dysphagia; Parkinson's disease; Rasagiline; DOSS; Deglutition; MAOB inhibitor; ROTIGOTINE TRANSDERMAL PATCH;
D O I：
10.1016/j.parkreldis.2020.07.010
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：98 / 99
页数：2
相关论文
共 50 条
  • [21] Rasagiline in Parkinson's Disease REPLY
    Olanow, C. Warren
    Rascol, Olivier
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (07): : 658 - 659
  • [22] Rasagiline (Azilect) for Parkinson's disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1249): : 97 - 99
  • [23] Effects of rasagiline on olfactory function in patients with Parkinson's disease
    Haehner, A.
    Hummel, T.
    Wolz, M.
    Klingelhoefer, L.
    Fauser, M.
    Storch, A.
    Reichmann, H.
    MOVEMENT DISORDERS, 2013, 28 : S141 - S141
  • [24] Safety of rasagiline in elderly Parkinson's disease (PD) patients
    Goetz, CG
    Schwid, SR
    Eberly, SW
    Oakes, D
    Shoulson, I
    MOVEMENT DISORDERS, 2005, 20 : S81 - S81
  • [25] The use of rasagiline in Parkinson's disease
    Schapira, A. H. V.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (71): : 157 - 161
  • [26] Spotlight on Rasagiline in Parkinson’s Disease
    Vicki Oldfield
    Gillian M. Keating
    Caroline M. Perry
    CNS Drugs, 2008, 22 : 83 - 86
  • [27] Effects of Rasagiline on Olfactory Function in Patients With Parkinson's Disease
    Haehner, Antje
    Hummel, Thomas
    Wolz, Martin
    Klingelhoefer, Lisa
    Fauser, Mareike
    Storch, Alexander
    Reichmann, Heinz
    MOVEMENT DISORDERS, 2013, 28 (14) : 2023 - 2027
  • [28] Spotlight on rasagiline in Parkinson's disease
    Oldfield, Vicki
    Keating, Gillian M.
    Perry, Caroline M.
    CNS DRUGS, 2008, 22 (01) : 83 - 86
  • [29] Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages
    Pagonabarraga, Javier
    Cruz Rodriguez-Oroz, Maria
    REVISTA DE NEUROLOGIA, 2013, 56 (01) : 25 - 34
  • [30] Rasagiline is effective as monotherapy in patients with early Parkinson's disease (PD) and as adjunctive therapy in moderate to advanced PD.
    Chen, JJ
    Berchou, RC
    PHARMACOTHERAPY, 2005, 25 (10): : 1466 - 1467
12345